Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.
about
First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacyPVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture.In vitro evaluation of viability, integrity, and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides.Expression of CCR5, CXCR4 and DC-SIGN in Cervix of HIV-1 Heterosexually Infected Mexican Women.Vaginal microbicides and the prevention of HIV transmissionHIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting CellsHIV sexual transmission and microbicides.Specific microbicides in the prevention of HIV infection.Beyond HIV microbicides: multipurpose prevention technology products.LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20.
P2860
Q21135264-8A93AAEC-8375-4FAF-9BB1-654D68317565Q34025640-E1303261-6B5B-41DA-8466-9C9C30AF3EDCQ34309533-0F744A04-A003-4420-AD14-19B4EE1D4A87Q36345852-82B3763C-0AE0-49C9-93AE-FFA65C742DD7Q37063819-C1446FBA-9EA5-4C3C-8ED8-5A8D71C9FA3FQ37287774-2F30A1F7-A59B-43A7-B949-7240024247EBQ37853935-CEE50820-8234-4584-BDA6-88A130392720Q37932048-6CB9EA7F-C331-45D3-8EAF-D5DF703C8BC6Q38261814-3A983947-E1A7-499E-99B5-5FA6463954D4Q39805693-79ACF9D1-B62D-4843-BEBC-DB4CD4036D38
P2860
Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Human immunodeficiency virus t ...... ll-associated HIV-1 infection.
@ast
Human immunodeficiency virus t ...... ll-associated HIV-1 infection.
@en
type
label
Human immunodeficiency virus t ...... ll-associated HIV-1 infection.
@ast
Human immunodeficiency virus t ...... ll-associated HIV-1 infection.
@en
prefLabel
Human immunodeficiency virus t ...... ll-associated HIV-1 infection.
@ast
Human immunodeficiency virus t ...... ll-associated HIV-1 infection.
@en
P2093
P2860
P50
P356
P1476
Human immunodeficiency virus t ...... ll-associated HIV-1 infection.
@en
P2093
Daria Hazuda
Guido Vanham
Katty Terrazas-Aranda
Yven Van Herrewege
P2860
P304
P356
10.1128/AAC.01627-07
P407
P577
2008-05-12T00:00:00Z